Get started

Nyse

Bread Financial Holdings (BFH) AnalysisInvestor Confidence and Financial Targets: Bread Financial Holdings NYSE:BFH is attracting investor interest after setting a medium-term ROTCE target in the low-to-mid 20% range, showing strong confidence in its business model. Market Outlook and Analyst Expectations: Analysts expect this to drive up valuation multiples, boosting the stock price. Improved credit sales and robust consumer spending, along with new partners and holiday spending, suggest a strong future for BFH. Investment Outlook: Bullish Outlook: We are bullish on BFH above the $37.00-$38.00 range. Upside Potential: With an upside target set at $56.00-$58.00, investors should consider Bread Financial's strategic financial targets and positive market trends as key drivers for potential stock growth. 📊💳 Keep an eye on Bread Financial Holdings for promising investment opportunities! #BFH #FinancialHoldings 📈🔍
NYSE:BFHLong
by Richtv_official
Comfort Systems USA (FIX) Analysis Benefiting from Macro Trends: Comfort Systems USA NYSE:FIX , specializing in HVAC services, stands to benefit significantly from key macroeconomic trends. The post-pandemic surge in nonresidential construction, especially in manufacturing, driven by initiatives like the CHIPS and Science Act of 2022, creates substantial opportunities for the company. Strategic Positioning: The CHIPS Act and supply chain challenges emphasize local sourcing, particularly for semiconductors, positioning Comfort Systems favorably amid this strategic shift. Geopolitical and demographic trends, coupled with advancements in industrial software and automation, further support reshoring and domestic technological investments, enhancing Comfort Systems' growth prospects. Investment Outlook: Bullish Outlook: We are bullish on FIX above the $275.00-$277.00 range. Upside Potential: With an upside target set at $445.00-$450.00, investors should consider Comfort Systems' strategic alignment with macroeconomic trends and its strong position in HVAC services as key drivers for potential stock appreciation. 📊🔧 Stay informed about Comfort Systems USA for promising investment opportunities! #FIX #HVACServices 🌐🛠️
NYSE:FIXLong
by Richtv_official
Pan American Silver (PAAS) AnalysisStrategic Portfolio Optimization: Pan American Silver NYSE:PAAS , a prominent global precious metal mining company, is bolstering its market position through strategic initiatives. Recently, PAAS agreed to sell its Lucita property to Defiance Silver and its La Arena gold property in Peru to Jinteng Mining for $245 million upfront, plus contingent payments. These moves align with PAAS's strategy to optimize its portfolio and strengthen its financial position. Leadership Insight: CEO Michael Steinmann highlighted the strategic benefits, stating, "With the sale of La Arena, we continue to optimize our portfolio while retaining future upside through royalties." Investment Outlook: Bullish Outlook: We are bullish on PAAS above the $16.50-$17.00 range. Upside Potential: With a target set at $28.00-$30.00, investors should consider PAAS's enhanced financial outlook and strategic portfolio optimization as key drivers for potential stock appreciation. 📊⚒️ Stay informed about Pan American Silver for promising investment opportunities! #PAAS #PreciousMetals 📈🔍
NYSE:PAASLong
by Richtv_official
DaVita (DVA) AnalysisLeading Dialysis Service Provider: DaVita NYSE:DVA stands as a top kidney dialysis service provider in the U.S., demonstrating strong resilience post-COVID-19. CEO Javier Rodriguez emphasized the company's strengthened position and continued investments in staff and systems. Expansive Market Potential: With 40 million Americans affected by kidney disease, the dialysis market is valued at an impressive $100 billion. DaVita, as a major player, serves a significant portion of the 786,000 people requiring dialysis or transplants annually. Financial Performance: DaVita boasts a robust financial performance with a remarkable 53% Return on Equity (ROE) over the past five years, indicating effective value creation and investor capital management. Investment Outlook: Bullish Outlook: We are bullish on DVA above the $125.00-$126.00 range. Upside Potential: With a target set at $195.00-$200.00, DaVita’s strong market position and impressive financial metrics suggest strong growth potential in this essential healthcare sector. 📊🩺 Stay tuned for promising investment opportunities with DaVita! #DVA #HealthcareServices 📈🔍
NYSE:DVALong
by Richtv_official
Trade Like A Sniper - Episode 25 - BABA - (8th June 2024)This video is part of a video series where I backtest a specific asset using the TradingView Replay function, and perform a top-down analysis using ICT's Concepts in order to frame ONE high-probability setup. I choose a random point of time to replay, and begin to work my way down the timeframes. Trading like a sniper is not about entries with no drawdown. It is about careful planning, discipline, and taking your shot at the right time in the best of conditions. A couple of things to note: - I cannot see news events. - I cannot change timeframes without affecting my bias due to higher-timeframe candles revealing its entire range. - I cannot go to a very low timeframe due to the limit in amount of replayed candlesticks In this session I will be analyzing Alibaba (BABA), starting from the 6-Month chart. If you want to learn more, check out my other videos on TradingView or on YT. If you are interested in private coaching, feel free to get in touch via one of my socials.
NYSE:BABAEducation
by Road_2_Funded
Elanco Animal Health (ELAN) AnalysisMarket Position: Elanco Animal Health NYSE:ELAN focuses on innovating and marketing products for pets and farm animals. CEO Jeff Simmons credits the company's growth to "accelerating contribution from innovation, stabilizing core volumes, price growth, and improved market conditions in Europe." Sector Growth: Animal health is a promising sector for growth investors, driven by increasing pet ownership, with 70% of U.S. households now owning a pet, up from 56% in 1988. As a major player, Elanco stands to benefit significantly from this trend. Regulatory Approvals: Elanco recently received continued approval from the EPA and support from the FDA for its Seresto flea and tick collar for dogs and cats. This development opens a significant new revenue stream and is likely to drive the stock price higher. Investment Outlook: Bullish Outlook: We are bullish on ELAN above the $14.50-$15.00 range. Upside Potential: With a target set at $22.00-$23.00, investors should monitor Elanco’s innovations and market expansions, particularly with products like Seresto, to capitalize on the growing demand in animal healthcare. 📊🐾 Stay updated on Elanco Animal Health for promising investment opportunities! #ELAN #AnimalHealth 📈🔍
NYSE:ELANLong
by Richtv_official
Trade Like A Sniper - Episode 21 - INTC - (7th June 2024)This video is part of a video series where I backtest a specific asset using the TradingView Replay function, and perform a top-down analysis using ICT's Concepts in order to frame ONE high-probability setup. I choose a random point of time to replay, and begin to work my way down the timeframes. Trading like a sniper is not about entries with no drawdown. It is about careful planning, discipline, and taking your shot at the right time in the best of conditions. A couple of things to note: - I cannot see news events. - I cannot change timeframes without affecting my bias due to higher-timeframe candles revealing its entire range. - I cannot go to a very low timeframe due to the limit in amount of replayed candlesticks In this session I will be analyzing Intel (INTC), starting from the 6-Month chart.
NASDAQ:INTCEducation
by Road_2_Funded
Trade Like A Sniper - Episode 19 - BRK.B - (6th June 2024)This video is part of a video series where I backtest a specific asset using the TradingView Replay function, and perform a top-down analysis using ICT's Concepts in order to frame ONE high-probability setup. I choose a random point of time to replay, and begin to work my way down the timeframes. Trading like a sniper is not about entries with no drawdown. It is about careful planning, discipline, and taking your shot at the right time in the best of conditions. A couple of things to note: - I cannot see news events. - I cannot change timeframes without affecting my bias due to higher-timeframe candles revealing its entire range. - I cannot go to a very low timeframe due to the limit in amount of replayed candlesticks In this session I will be analyzing the Berkshire Hathaway ETF chart, starting from the 6-Month chart.
NYSE:BRK.B
by Road_2_Funded
Trade Like A Sniper - Episode 17- Ford Motors - (5th June 2024)This video is part of a video series where I backtest a specific asset using the TradingView Replay function, and perform a top-down analysis using ICT's Concepts in order to frame ONE high-probability setup. I choose a random point of time to replay, and begin to work my way down the timeframes. Trading like a sniper is not about entries with no drawdown. It is about careful planning, discipline, and taking your shot at the right time in the best of conditions. A couple of things to note: - I cannot see news events. - I cannot change timeframes without affecting my bias due to higher-timeframe candles revealing its entire range. - I cannot go to a very low timeframe due to the limit in amount of replayed candlesticks In this session I will be analyzing Ford Motors (F), starting from the 4-Month chart. - R2F
NYSE:F
by Road_2_Funded
Trade Like A Sniper - Episode 16 - Pfizer - (5th June 2024)This video is part of a video series where I backtest a specific asset using the TradingView Replay function, and perform a top-down analysis using ICT's Concepts in order to frame ONE high-probability setup. I choose a random point of time to replay, and begin to work my way down the timeframes. Trading like a sniper is not about entries with no drawdown. It is about careful planning, discipline, and taking your shot at the right time in the best of conditions. A couple of things to note: - I cannot see news events. - I cannot change timeframes without affecting my bias due to higher-timeframe candles revealing its entire range. - I cannot go to a very low timeframe due to the limit in amount of replayed candlesticks In this session I will be analyzing PFE (Pfizer), starting from the 4-Month chart. - R2F
NYSE:PFE
by Road_2_Funded